Gradient Investments
RDY icon

Gradient Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Gradient Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-285
Closed -$3.97K – 1704
2023
Q4 		$3.97K Hold
285
– – ﹤0.01% 1050
2023
Q3 		$3.81K Hold
285
– – ﹤0.01% 1020
2023
Q2 		$3.6K Buy
+285
New +$3.33K ﹤0.01% 1032

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gradient Investments's RDY Position: Q1 2024 in Review

Gradient Investments sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 285 shares — an estimated $3.97K sold.

Gradient Investments first reported a position in RDY in Q2 2023 and held it in 3 quarters. The position peaked at $3.97K in Q4 2023. 231 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • Gradient Investments reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 285 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $3.97K.
  • Gradient Investments first reported a position in Dr. Reddy's Laboratories in Q2 2023 and held it in 3 quarters.
  • Gradient Investments's Dr. Reddy's Laboratories position peaked at $3.97K in Q4 2023.
  • 231 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.